Osteonecrosis of the Jaws Associated with Medications with Possible Related Sepsis
DOI:
https://doi.org/10.21270/archi.v14i1.6293Keywords:
Bisphosphonates, Oral Surgery, Osteonecrosis, Sepsis, Platelet-Rich PlasmaAbstract
Sepsis is considered a syndrome that occurs as a result of the release of several cytokines and other mediators in response to an infectious process. It develops in a potentially severe way and has a high mortality rate. The diagnosis of medication-related osteonecrosis of the jaw (MRONJ) is becoming more prevalent, and it is a comorbidity that presents a high risk of infection development. Case reports that relate the diagnosis of sepsis to MRONJ are scarce in the literature, and the need for updates for early diagnosis and effective treatments are crucial in these conditions.
Downloads
References
1. Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg. 2022;80(5):920-943.
2. Caminha R D'A-G, Alcantara PL, Carvalho CG, Reia VCB, Capelozza ALA, Santos PSS. The impact of medication-related osteonecrosis of the jaws on the quality of life in cancer patients. J Clin Exp Dent. 2020;12(8):e725-e729.
3. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014;72(10):1938-56.
4. Yamashiro K, Sato A, Okazari F, Nakano M, Sawaki K, Hirata Y, et al. Medication-related osteonecrosis of the jaws caused lethal sepsis in an edentulous patient with multiple systemic factors. Clin Case Rep. 2016;5(2):97-103.
5. Viviano M, Addamo A, Cocca S. A case of bisphosphonate-related osteonecrosis of the jaw with a particularly unfavourable course: a case report. J Korean Assoc Oral Maxillofac Surg. 2017;43(4):272-275.
6. Yarom N, Shapiro CL, Peterson DE, Poznak CHV, Bohlke K, Ruggiero SL, et al. Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline. J Clin Oncol. 2019;37(25):2270-2290.
7. Vincent J-L. Sepsos definitions. Lancet Infect Dis. 2002;2(3):135.
8. Machado FR, Ferreira EM, Schippers P, de Paula IC, Saes LSV, de Oliveira Jr FI, et al. Implementation of sepsis bundles in public hospitals in Brazil: a prospective study with heterogeneous results. Crit Care. 2017;21(1):268
9. Kaehling CH, Streckbein PH, Schmermund D, Henrich M, Burchert D, Gattenloehner S, Howaldt H-P, Wilbrand J-F. Lethal cervical abscess following bisphosphonate related osteonecrosis of the jaw. J Craniomaxillofac Surg. 2014;42(7):1203-6.
10. Qaisi M, Hargett J, Loeb M, Brown J, Caloss R. Denosumab Related Osteonecrosis of the Jaw with Spontaneous Necrosis of the Soft Palate: Report of a Life Threatening Case. Case Rep Dent. 2016;2016:5070187.
11. Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg. 2015;44(5):568-85.
12. Martins MAT, Giglio A, Martins MD, Pavesi VCS, Lascala CA. Bisphosphonate-associated jaws osteonecrosis: an important complication of oncology treatment. Rev. Bras. Hematol. Hemoter. 2009;31(1):41-46.
13. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. J Oral Maxillofac Surg. 2009;67(5 Suppl):2-12.
14. Khan A, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, et al.Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015;30(1):3-23.
15. Maluf G, Jardim RC, Santos PSS. Use of leukocyte-and platelet-rich fibrin in the treatment of medication-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2018;76(1):88-96.
16. Mourão CFAB, Valiense H, Melo ER, Mourão NBMF, Maia MD-C. Obtention of injectable platelets rich-fibrin (i-PRF) and its polymerization with bone graft: technical note. Rev Col Bras Cir. 2015;42(6):421-423.
17. Soydan SS, Uckan S. Management of bisphosphonate-related osteonecrosis of the jaw with a platelet-rich fibrin membrane: technical report. J Oral Maxillofac Surg. 2014;72(2):322-6.
